SCHEMBL7985879

SCHEMBL7985879

CC(C)(C)OC(=O)NCC(=O)N1CCCN(CCCc2ccccc2)CC1

nearest known ligand 0.92

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 10/20 0.92
CHRM3 P20309 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
FAAH O00519 1/20 0.49
DRD2 P14416 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7986224 0.96 SIGMAR1 (1.00) SIGMAR1FAAHDRD2
SCHEMBL7971891 0.94 SIGMAR1 (0.80) SIGMAR1L3MBTL1DRD2
SCHEMBL7983465 0.89 SIGMAR1 (0.87) SIGMAR1DRD2
SCHEMBL7989733 0.84 SIGMAR1 (0.64) SIGMAR1CHRM3FAAH
SCHEMBL1222005 0.82 SIGMAR1 (0.76) SIGMAR1
SCHEMBL7985885 0.79 SIGMAR1 (0.59) SIGMAR1CHRM3FAAH
SCHEMBL7971782 0.79 SIGMAR1 (0.69) SIGMAR1FAAH
SCHEMBL8526553 0.78 SIGMAR1 (0.59) SIGMAR1CHRM3
SCHEMBL22151422 0.78 SIGMAR1 (0.62) SIGMAR1DRD2
SCHEMBL7985958 0.78 SIGMAR1 (0.68) SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235731-B1 REDUCING BLOOD LIPIDS, SUGARS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-22 US disclosed
EP-0915888-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS Takeda Chemical Industries, Ltd. (JP) 1999-05-19 EP disclosed
WO-1997040051-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-10-30 WO disclosed